IMR Press / EJGO / Volume 31 / Issue 6 / pii/1630990938633-24333262

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Overall survival in BRCA-associated ovarian cancer: case-control study of an Italian series
Show Less
1 Department of Medical Science, Oncology-Haematology Department, Mirano/Venice, Veneto Oncology Istitute I.O.V., Padova
1 Department of Obstetrics and Gynecology, Mirano/Venice Surgery Clinic II, University of Padova (Italy)
Eur. J. Gynaecol. Oncol. 2010, 31(6), 658–661;
Published: 10 December 2010

About 10% of all ovarian cancers are due to BRCA 1 and/or BRCA 2 mutations. Some studies have shown that patients belonging to this group have a better survival compared to sporadic groups but data are still inconclusive. The aim of this study was to investigate overall survival in patients with ovarian cancer and germ-line mutations in the BRCA1/2 genes in comparison to highrisk patients, defined as patients with ovarian cancer and a strong family history of breast and ovarian cancer, but who tested negative for the BRCA mutation. We collected all the clinical features and did follow-up. The two groups showed similar characteristics concerning age at diagnosis, histological type and stage. Grade 3 was more frequent in the BRCA group. Survival data did not show any advantage for the BRCA mutated group.
Ovarian cancer
Back to top